LIVE WEBINAR - HER2-Low and Ultralow Metastatic Breast Cancer: Evolving Definitions, Emerging Evidence, and Shifting Treatment Paradigms

Created by oncoXchange

August 2025

0

 PIN

LIVE WEBINAR - REGISTER NOW

az_webinar_banner_10sep2025_en_1920_v3.jpg#asset:20618

EAST COAST: Wednesday September 10, 2025 18:30 EDT

Join us for a timely and informative webinar on HER2-Low and Ultralow Metastatic Breast Cancer: Evolving Definitions, Emerging Evidence, and Shifting Treatment Paradigms, featuring internationally recognized breast medical oncologist Dr. Neil Iyengar, who will share the latest insights and clinical trial data shaping global practice. Providing the Canadian perspective is Dr. Nicholas Meti, a respected clinician in the breast cancer field, who will moderate the session and highlight how these advances are being applied in Canadian care settings. Don't miss this opportunity to gain expert guidance on navigating the evolving landscape of HER2-low and ultralow disease.


az_webinar_banner_16sep2025_en_1920_v3.jpg#asset:20627

WEST COAST: Tuesday September 16, 2025 18:30 PDT

Join us for a timely and informative West Coast-timed webinar on HER2-Low and Ultralow Metastatic Breast Cancer: Evolving Definitions, Emerging Evidence, and Shifting Treatment Paradigms, featuring internationally recognized breast medical oncologist Dr. Aditya Bardia, who will share the latest insights and clinical trial data shaping global practice. Offering the Canadian perspective is Dr. Mita Manna, a respected breast cancer expert based in Western Canada, who will moderate the session and explore how these evolving advances are being integrated into clinical care across the region. Don't miss this opportunity to gain valuable guidance on navigating the changing landscape of HER2-low and ultralow disease.